HSN chapter guide
Chapter 30 — Pharmaceutical products
226 eight-digit tariff lines. Rates below are from the Indian Customs Tariff First Schedule. Use the AI HSN classifier if you only have a product description. Reviewed by the CustomsAI compliance desk · 24 August 2026.
Chapter notes
- This Chapter does not cover: (a) Foods or beverages (such as dietetic, diabetic or fortified foods, food supplements, tonic beverages and mineral waters), other than nutritional preparations for intravenous administration (Section IV); (b) Products, such as tablets, chewing gum or patches (transdermal systems), containing nicotine and intended to assist tobacco use cessation (heading 24.04); (c) Plasters specially calcined or finely ground for use in dentistry (heading 25.20); (d) Aqueous distillates or aqueous solutions of essential oils, suitable for medicinal uses (heading 33.01); (e) Preparations of headings 33.03 to 33.07, even if they have therapeutic or prophylactic properties; (f) Soap or other products of heading 34.01 containing added medicaments; (g) Preparations with a basis of plaster for use in dentistry (heading 34.07); (h) Blood albumin not prepared for therapeutic or prophylactic uses (heading 35.02); (i) Diagnostic reagents of heading 38.22.
- For the purposes of heading 30.02, the expression 'immunological products' applies to peptides and proteins (other than goods of heading 29.37) which are directly involved in the regulation of immunological processes, such as monoclonal antibodies (MAB), antibody fragments, antibody conjugates and antibody fragment conjugates, interleukins, interferons (IFN), chemokines and certain tumour necrosis factors (TNF), growth factors (GF), hematopoietins and colony stimulating factors (CSF).
- For the purposes of headings 30.03 and 30.04 and of Note 4(d), the following are to be treated: (a) As unmixed products: (1) Unmixed products dissolved in water; (2) All goods of Chapter 28 or 29; and (3) Simple vegetable extracts of heading 13.02, merely standardised or dissolved in any solvent; (b) As products which have been mixed: (1) Colloidal solutions and suspensions (other than colloidal sulphur); (2) Vegetable extracts obtained by the treatment of mixtures of vegetable materials; and (3) Salts and concentrates obtained by evaporating natural mineral waters.
- Heading 30.06 applies only to the following, which are to be classified in that heading and in no other heading of the Nomenclature: (a) Sterile surgical catgut, sterile suture materials, sterile tissue adhesives; (b) Sterile laminaria and laminaria tents; (c) Sterile absorbable haemostatics; sterile adhesion barriers; (d) Opacifying preparations for X-ray examinations and diagnostic reagents designed to be administered to the patient; (e) Placebos and blinded clinical trial kits; (f) Dental cements and other dental fillings; bone reconstruction cements; (g) First-aid boxes and kits; (h) Chemical contraceptive preparations based on hormones or spermicides; (i) Gel preparations for use in human or veterinary medicine as lubricant or coupling agent; (k) Waste pharmaceuticals; (l) Appliances identifiable for ostomy use.
Sample 8-digit lines
| HSN | Description | BCD |
|---|---|---|
| 3001 20 10 | Liquid extracts of liver | 10% |
| 3001 20 20 | Liver extracts, dry | 10% |
| 3001 20 30 | Snake venom | 10% |
| 3001 20 90 | Other | 10% |
| 3001 90 10 | Of human origin | 10% |
| 3001 90 91 | Heparin and its salts | 10% |
| 3001 90 99 | Other | 10% |
| 3002 12 10 | For diphtheria | 10% |
| 3002 12 20 | For tetanus | 10% |
| 3002 12 30 | For rabies | 10% |
| 3002 12 40 | For snake venom | 10% |
| 3002 12 90 | Other | 10% |
| 3002 13 00 | Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale | 10% |
| 3002 14 00 | Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale | 10% |
| 3002 15 00 | Immunological products, put up in measured doses or in forms or packings for retail sale | 10% |
| 3002 41 11 | Cholera and typhoid | 10% |
| 3002 41 12 | Hepatitis | 10% |
| 3002 41 13 | Tetanus | 10% |
| 3002 41 14 | Polio | 10% |
| 3002 41 15 | Tuberculosis | 10% |
| 3002 41 16 | Rabies | 10% |
| 3002 41 17 | Japanese encephalitis | 10% |
| 3002 41 18 | Whooping cough (pertussis) | 10% |
| 3002 41 19 | Other | 10% |
| 3002 41 21 | Diphtheria, pertussis and tetanus(DPT) | 10% |
| 3002 41 22 | Diphtheria and tetanus (DT) | 10% |
| 3002 41 23 | Measles, mumps and rubella(MMR) | 10% |
| 3002 41 24 | Typhoid-paratyphoid (TAB) | 10% |
| 3002 41 25 | Typhoid- paratyphoid-cholera (TABC) | 10% |
| 3002 41 29 | Other | 10% |
| 3002 42 00 | Vaccines for veterinary medicine | 10% |
| 3002 49 10 | Cultures of micro-organisms(excluding yeast) | 10% |
| 3002 49 20 | Toxins | 10% |
| 3002 49 90 | Other | 10% |
| 3002 51 00 | Cell therapy products | 10% |
| 3002 59 00 | Other | 10% |
| 3002 90 10 | Human blood | 10% |
| 3002 90 20 | Animal blood prepared for therapeutic, prophylactic or diagnostic uses | 10% |
| 3002 90 90 | Other | 10% |
| 3003 10 00 | Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives | 10% |